PBS dispute could see MS patients pay thousands for crucial drugs Ocrevus and Kesimpta
A dispute over how Australia prices medicines has sparked fears 10,000 people with multiple sclerosis will be forced…
Global drug makers face pricing pressure as China targets affordable healthcare
Global pharmaceutical companies posted mixed earnings in China last year, with some firms warning that 2026 will be…
Genomics, multiomics, and spatial biology at AGBT 2026
Key Insights Sequencing companies frequently launch new instruments and chemistries at the Advances in Genome Biology and…
Shanghai to scrap all foreign investment limits on manufacturing facilities
Mainland China’s commercial and financial hub Shanghai has pledged to remove all regulatory hurdles for foreign investors to…